SCHEMBL7350833

SCHEMBL7350833

COC(=O)C(C(=O)OCc1ccccc1)N1CCN(C)CC1

nearest known ligand 0.49

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
IDO1 P14902 1/20 0.49
CSNK1A1 P48729 1/20 0.46
TMEM97 Q5BJF2 4/20 0.46
SIGMAR1 Q99720 4/20 0.46
HTR1A P08908 1/20 0.46
ADRA2A P08913 1/20 0.46
ADRA2B P18089 1/20 0.46
ADRA2C P18825 1/20 0.46
DRD1 P21728 1/20 0.46
HRH2 P25021 1/20 0.46
HTR1B P28222 1/20 0.46
HTR2A P28223 1/20 0.46
HTR2C P28335 1/20 0.46
HTR1E P28566 1/20 0.46
SLC6A4 P31645 1/20 0.46
HRH1 P35367 1/20 0.46
HTR2B P41595 1/20 0.46
HRH3 Q9Y5N1 1/20 0.46
ALDH1A1 P00352 3/20 0.44
HSD17B10 Q99714 1/20 0.44

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL7343776 0.89 ALDH1A1 (0.52) SIGMAR1ALDH1A1RAB9ANPC1SMN1; SMN2
SCHEMBL7340543 0.88 ALDH1A1 (0.55) SIGMAR1ALDH1A1RAB9ANPC1SMN1; SMN2
SCHEMBL7349999 0.85 MEN1 (0.56) ALDH1A1HSD17B10RAB9ANPC1SMN1; SMN2
SCHEMBL21103823 0.82 HSD17B10 (0.50) IDO1CSNK1A1TMEM97SIGMAR1HTR1A
SCHEMBL27306803 0.81 ALDH1A1 (0.49) ALDH1A1RAB9ANPC1SMN1; SMN2CYP3A4
SCHEMBL305765 0.80 ALDH1A1 (0.51) IDO1CSNK1A1TMEM97SIGMAR1HTR1A
SCHEMBL23130581 0.79 MAPT (0.46) IDO1TMEM97SIGMAR1HTR1AADRA2A
SCHEMBL20399260 0.79 MAPT (0.46) IDO1TMEM97SIGMAR1HTR1AADRA2A
SCHEMBL20666387 0.77 ALDH1A1 (0.45) IDO1CSNK1A1TMEM97SIGMAR1HTR1A
SCHEMBL9224504 0.76 ALDH1A1 (0.46) SIGMAR1ALDH1A1RAB9ANPC1SMN1; SMN2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 5 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-5436240-A Schizophrenia, Parkinson's disease, depression or hypotensive agents using tricyclic amines THE UPJOHN COMPANY (US) 1995-07-25 US disclosed
EP-0480939-B1 HETEROCYCLIC AMINES HAVING CENTRAL NERVOUS SYSTEM ACTIVITY UPJOHN CO (US) 1995-01-25 EP disclosed
US-5273975-A Heterocyclic amines having central nervous system activity THE UPJOHN COMPANY (US) 1993-12-28 US disclosed
EP-0480939-A1 HETEROCYCLIC AMINES HAVING CENTRAL NERVOUS SYSTEM ACTIVITY. UPJOHN CO (US) 1992-04-22 EP disclosed
WO-1990015058-A1 HETEROCYCLIC AMINES HAVING CENTRAL NERVOUS SYSTEM ACTIVITY THE UPJOHN COMPANY (US) 1990-12-13 WO disclosed